Alcoholism is a chronic relapsing disorder characterized by periods of high alcohol intake (binges), acute withdrawal, protracted abstinence and relapse. Particularly important is the stage of protracted abstinence which can be defined as a state of heightened reactivity to aversive and appetitive stimuli long after acute withdrawal that conveys a vulnerability to relapse in individuals with a history of dependence. Animal models exist for all stages of the addiction cycle and have been useful in elucidating the neurobiological basis for vulnerability to alcoholism. The purpose of this proposal is to establish animal and human models of various stages of the addiction cycle with a focus on predicting efficacy of medications to treat the protracted abstinence stage of the alcoholic syndrome and protect against relapse. Preliminary studies have shown that rats can be trained to self-administer alcohol and, when made dependent, increase their consumption during acute withdrawal and long after acute withdrawal. Studies are proposed to further characterize and develop these animal models of the addiction cycle. Neuropharmacological agents known to alter reward dysregulation will be tested on these models (Specific Aim 1) to identify novel potential treatments for human laboratory testing (Specific Aim 2). In parallel, a human experimental model of various components of the addiction cycle will be developed and validated using cue reactivity and mood induction techniques in the lab and assessment of drinking, mood and sleep under natural conditions (Specific Aim 3). The optimal parameters of the human laboratory model will be used to evaluate potential treatments for various components of the addiction cycle (Specific Aim 4), drawing on the pharmacological agents identified in the animal models of Specific Aim 2. A focus on various components of the addiction cycle in alcoholism is critical for understanding vulnerability to relapse, and the results of the present proposed studies will provide novel treatments for such components including protracted abstinence and thus unique approaches to alcoholism treatment.

Agency
National Institute of Health (NIH)
Institute
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Type
Research Project (R01)
Project #
2R01AA012602-06A1
Application #
6969185
Study Section
Special Emphasis Panel (ZAA1-CC (34))
Program Officer
Litten, Raye Z
Project Start
1999-09-25
Project End
2010-06-30
Budget Start
2005-08-05
Budget End
2006-06-30
Support Year
6
Fiscal Year
2005
Total Cost
$818,653
Indirect Cost
Name
Scripps Research Institute
Department
Type
DUNS #
781613492
City
La Jolla
State
CA
Country
United States
Zip Code
92037
Kimbrough, Adam; de Guglielmo, Giordano; Kononoff, Jenni et al. (2017) CRF1 Receptor-Dependent Increases in Irritability-Like Behavior During Abstinence from Chronic Intermittent Ethanol Vapor Exposure. Alcohol Clin Exp Res 41:1886-1895
Mason, Barbara J (2017) Emerging pharmacotherapies for alcohol use disorder. Neuropharmacology 122:244-253
Harris, R Adron; Bajo, Michal; Bell, Richard L et al. (2017) Genetic and Pharmacologic Manipulation of TLR4 Has Minimal Impact on Ethanol Consumption in Rodents. J Neurosci 37:1139-1155
Varodayan, Florence P; de Guglielmo, Giordano; Logrip, Marian L et al. (2017) Alcohol Dependence Disrupts Amygdalar L-Type Voltage-Gated Calcium Channel Mechanisms. J Neurosci 37:4593-4603
de Guglielmo, Giordano; Kallupi, Marsida; Cole, Maury D et al. (2017) Voluntary induction and maintenance of alcohol dependence in rats using alcohol vapor self-administration. Psychopharmacology (Berl) 234:2009-2018
Kimbrough, Adam; Kim, Sarah; Cole, Maury et al. (2017) Intermittent Access to Ethanol Drinking Facilitates the Transition to Excessive Drinking After Chronic Intermittent Ethanol Vapor Exposure. Alcohol Clin Exp Res 41:1502-1509
George, Olivier; Hope, Bruce T (2017) Cortical and amygdalar neuronal ensembles in alcohol seeking, drinking and withdrawal. Neuropharmacology 122:107-114
de Guglielmo, Giordano; Crawford, Elena; Kim, Sarah et al. (2016) Recruitment of a Neuronal Ensemble in the Central Nucleus of the Amygdala Is Required for Alcohol Dependence. J Neurosci 36:9446-53
Koob, George F; Mason, Barbara J (2016) Existing and Future Drugs for the Treatment of the Dark Side of Addiction. Annu Rev Pharmacol Toxicol 56:299-322
Cui, Changhai; Noronha, Antonio; Warren, Kenneth R et al. (2015) Brain pathways to recovery from alcohol dependence. Alcohol 49:435-52

Showing the most recent 10 out of 50 publications